Nitazoxanide is active against Mycobacterium leprae

por Bailey, Mai Ann, Na, Hana, Duthie, Malcolm S., Gillis, Thomas P., Lahiri, Ramanuj, Parish, Tanya
Publicado 2017

Enumeration of Mycobacterium leprae Using Real-Time PCR

por Truman, Richard W., Andrews, P. Kyle, Robbins, Naoko Y., Adams, Linda B., Krahenbuhl, James L., Gillis, Thomas P.
Publicado 2008

Molecular Assays for Determining Mycobacterium leprae Viability in Tissues of Experimentally Infected Mice

por Davis, Grace L., Ray, Nashone A., Lahiri, Ramanuj, Gillis, Thomas P., Krahenbuhl, James L., Williams, Diana L., Adams, Linda B.
Publicado 2013

LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection

por Duthie, Malcolm S., Pena, Maria T., Ebenezer, Gigi J., Gillis, Thomas P., Sharma, Rahul, Cunningham, Kelly, Polydefkis, Michael, Maeda, Yumi, Makino, Masahiko, Truman, Richard W., Reed, Steven G.
Publicado 2018

Author Correction: LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection

por Duthie, Malcolm S., Pena, Maria T., Ebenezer, Gigi J., Gillis, Thomas P., Sharma, Rahul, Cunningham, Kelly, Polydefkis, Michael, Maeda, Yumi, Makino, Masahiko, Truman, Richard W., Reed, Steven G.
Publicado 2018

Implications of high level pseudogene transcription in Mycobacterium leprae

por Williams, Diana L, Slayden, Richard A, Amin, Amol, Martinez, Alejandra N, Pittman, Tana L, Mira, Alex, Mitra, Anirban, Nagaraja, Valakunja, Morrison, Norman E, Moraes, Milton, Gillis, Thomas P
Publicado 2009